Celldex Therapeutics
CLDX
#4502
Rank
$2.48 B
Marketcap
$31.64
Share price
0.48%
Change (1 day)
20.81%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2026 (TTM): -$0.33 Billion USD

According to Celldex Therapeutics's latest financial reports the company's current earnings are $0.15 Million USD. In 2025 the company made an earning of -$0.29 Billion USD a decrease over its 2024 earnings that were of -$0.2 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.33 Billion13.38%
2025 -$0.29 Billion47.31%
2024 -$0.2 Billion37.34%
2023 -$0.15 Billion32.63%
2022 -$0.11 Billion54.88%
2021 -$69.15 Million39.49%
2020 -$49.58 Million-9.08%
2019 -$54.53 Million-28.64%
2018 -$76.41 Million-30.11%
2017 -$0.11 Billion-17.75%
2016 -$0.14 Billion4.5%
2015 -$0.13 Billion4.09%
2014 -$0.13 Billion51.57%
2013 -$80.63 Million40.1%
2012 -$57.55 Million
2010 -$1.25 Million-96.59%
2009 -$36.61 Million
2006 -$22.37 Million
2004 -$13.59 Million15.75%
2003 -$11.74 Million-18.69%
2002 -$14.44 Million-41.22%
2001 -$24.56 Million59%
2000 -$15.45 Million27.65%
1999 -$12.1 Million53.12%
1998 -$7.9 Million2.6%
1997 -$7.7 Million-33.62%
1996 -$11.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$6.90 B-2,219.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$10.28 B-3,257.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$7.88 B-2,521.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-$2.81 Million-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-$0.8 Billion 142.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$0.15 B-146.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-$95.1 Million-70.81%๐Ÿ‡บ๐Ÿ‡ธ USA